Gregory J. Tobin

1.7k total citations
49 papers, 1.3k citations indexed

About

Gregory J. Tobin is a scholar working on Molecular Biology, Immunology and Epidemiology. According to data from OpenAlex, Gregory J. Tobin has authored 49 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Immunology and 12 papers in Epidemiology. Recurrent topics in Gregory J. Tobin's work include Virus-based gene therapy research (9 papers), Animal Disease Management and Epidemiology (9 papers) and HIV Research and Treatment (7 papers). Gregory J. Tobin is often cited by papers focused on Virus-based gene therapy research (9 papers), Animal Disease Management and Epidemiology (9 papers) and HIV Research and Treatment (7 papers). Gregory J. Tobin collaborates with scholars based in United States, Iceland and United Kingdom. Gregory J. Tobin's co-authors include Alexander Wlodawer, Matthew A. Gonda, Alexander Zdanov, Jukka Kervinen, Júlia Costa, Dorothy C. Young, James B. Flanegan, Peter L. Nara, David S. Waugh and Kunio Nagashima and has published in prestigious journals such as Cell, Journal of Biological Chemistry and The EMBO Journal.

In The Last Decade

Gregory J. Tobin

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory J. Tobin United States 21 517 346 324 253 239 49 1.3k
Isidro Hötzel United States 19 687 1.3× 373 1.1× 284 0.9× 254 1.0× 119 0.5× 57 1.4k
Krystyna Bieńkowska-Szewczyk Poland 22 500 1.0× 292 0.8× 695 2.1× 118 0.5× 200 0.8× 61 1.5k
Patricia Whitaker‐Dowling United States 23 347 0.7× 310 0.9× 589 1.8× 129 0.5× 429 1.8× 51 1.3k
Jean K. Gustin United States 16 597 1.2× 292 0.8× 370 1.1× 454 1.8× 235 1.0× 24 1.4k
D Schmitt France 20 487 0.9× 413 1.2× 394 1.2× 681 2.7× 287 1.2× 55 1.5k
Jerry L. Blackwell United States 20 650 1.3× 425 1.2× 282 0.9× 449 1.8× 638 2.7× 36 1.8k
Mitra C. Singhal United States 14 341 0.7× 342 1.0× 295 0.9× 306 1.2× 121 0.5× 20 1.1k
Hanns-Joachim Rziha Germany 23 191 0.4× 330 1.0× 633 2.0× 284 1.1× 353 1.5× 35 1.3k
Michael R. Knittler Germany 19 613 1.2× 441 1.3× 331 1.0× 103 0.4× 125 0.5× 43 1.4k
Jürgen Brojatsch United States 21 897 1.7× 551 1.6× 478 1.5× 475 1.9× 379 1.6× 29 1.6k

Countries citing papers authored by Gregory J. Tobin

Since Specialization
Citations

This map shows the geographic impact of Gregory J. Tobin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory J. Tobin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory J. Tobin more than expected).

Fields of papers citing papers by Gregory J. Tobin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory J. Tobin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory J. Tobin. The network helps show where Gregory J. Tobin may publish in the future.

Co-authorship network of co-authors of Gregory J. Tobin

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory J. Tobin. A scholar is included among the top collaborators of Gregory J. Tobin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory J. Tobin. Gregory J. Tobin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yun, et al.. (2025). Multiple-Channel Funnel Adapted Sensing Tube (MFAST) for the Simple and Duplex Detection of Parasites. ACS Sensors. 10(4). 2678–2688. 1 indexed citations
2.
Tobin, Gregory J., et al.. (2024). A highly immunogenic UVC inactivated Sabin based polio vaccine. npj Vaccines. 9(1). 217–217. 2 indexed citations
3.
Tobin, Gregory J., et al.. (2024). Instrument-Free Point-of-Care Diagnostic for Leishmania Parasites. Diagnostics. 14(23). 2744–2744. 2 indexed citations
4.
Bao, Mengdi, et al.. (2023). Micropillar enhanced FRET-CRISPR biosensor for nucleic acid detection. Lab on a Chip. 24(1). 47–55. 9 indexed citations
5.
Liu, Li, Zhiheng Xu, Stephen J. Dollery, et al.. (2022). Gold Nanoparticle‐Labeled CRISPR‐Cas13a Assay for the Sensitive Solid‐State Nanopore Molecular Counting. Advanced Materials Technologies. 7(3). 22 indexed citations
6.
7.
Dollery, Stephen J., Daniel V. Zurawski, David MacLeod, et al.. (2022). Whole-cell vaccine candidates induce a protective response against virulent Acinetobacter baumannii. Frontiers in Immunology. 13. 941010–941010. 9 indexed citations
8.
Tobin, Gregory J., Linh Pham, Rebecca A. Nace, et al.. (2013). Epitope Dampening Monotypic Measles Virus Hemagglutinin Glycoprotein Results in Resistance to Cocktail of Monoclonal Antibodies. PLoS ONE. 8(1). e52306–e52306. 18 indexed citations
9.
Butler, John E., Nancy Wertz, Kelly M. Lager, et al.. (2011). Antibody repertoire development in fetal and neonatal piglets. Molecular Immunology. 49(3). 483–494. 53 indexed citations
10.
Long, Jinxue, et al.. (2011). Evolution of H3N2 Influenza Virus in a Guinea Pig Model. PLoS ONE. 6(7). e20130–e20130. 20 indexed citations
11.
Eguchi-Ogawa, Tomoko, Nancy Wertz, Xiuzhu Sun, et al.. (2010). Antibody Repertoire Development in Fetal and Neonatal Piglets. XI. The Relationship of Variable Heavy Chain Gene Usage and the Genomic Organization of the Variable Heavy Chain Locus. The Journal of Immunology. 184(7). 3734–3742. 33 indexed citations
12.
Nara, Peter L., Gregory J. Tobin, Abhijit Chaudhuri, et al.. (2010). How Can Vaccines Against Influenza and Other Viral Diseases Be Made More Effective?. PLoS Biology. 8(12). e1000571–e1000571. 22 indexed citations
13.
Long, Jinxue, et al.. (2010). Serological characterization of guinea pigs infected with H3N2 human influenza or immunized with hemagglutinin protein. Virology Journal. 7(1). 200–200. 8 indexed citations
14.
Howard, O. M. Zack, Aiko‐Konno Shirakawa, Jim A. Turpin, et al.. (1999). Naturally Occurring CCR5 Extracellular and Transmembrane Domain Variants Affect HIV-1 Co-receptor and Ligand Binding Function. Journal of Biological Chemistry. 274(23). 16228–16234. 65 indexed citations
16.
Derse, David, Luke A. Pallansch, Terry Copeland, et al.. (1997). Bovine Immunodeficiency VirustatGene: Cloning of Two Distinct cDNAs and Identification, Characterization, and Immunolocalization of thetatGene Products. Virology. 233(2). 339–357. 11 indexed citations
17.
Tobin, Gregory J., Willis H. Ennis, David J. Clanton, & Matthew A. Gonda. (1996). Inhibition of bovine immunodeficiency virus by anti-HIV-1 compounds in a cell culture-based assay. Antiviral Research. 33(1). 21–31. 12 indexed citations
18.
Tobin, Gregory J., Kunio Nagashima, & Matthew A. Gonda. (1996). Synthesis and Assembly of Chimeric Human Immunodeficiency Virus Gag Pseudovirions. Intervirology. 39(1-2). 40–48. 9 indexed citations
20.
Tobin, Gregory J., Dorothy C. Young, & James B. Flanegan. (1989). Self-catalyzed linkage of poliovirus terminal protein VPg to poliovirus RNA. Cell. 59(3). 511–519. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026